Qure.ai Overview
Pro stress-test →Qure.ai is a health tech company that uses deep learning and artificial intelligence to make healthcare more equitable for patients worldwide, with solutions backed by multiple FDA clearances that power efficient identification and management of diseases including lung cancer, tuberculosis (TB), pediatric TB, and stroke. The company's qXR tool detects tuberculosis with 95% accuracy on chest X-rays and has been deployed in over 90 countries.
Strategic Profile
Pro stress-test →Qure.ai equips low-resource settings, diagnosing over 10 million cases yearly. The company operates partnerships across public and private sectors including Ministries of Health in Kenya, Egypt, and Thailand, works with over 25 NHS sites in the UK processing over a million scans annually, and partners with companies like AstraZeneca, Medtronic, and Fujifilm to deliver AI-powered diagnostics to underserved regions worldwide.
Competitive Landscape
Pro stress-test →Qure.ai competes with PathAI in pathology analysis, RapidAI in vascular imaging, and Annalise.ai with broad multi-indication detection capabilities. Other key competitors include Rad AI for radiological reporting and Viz.ai for stroke triage. Qure.ai differentiates through its focus on low-resource settings, hardware-agnostic deployment, and WHO endorsement for TB screening.
Industry Context
Qure.ai operates in Medical imaging AI diagnostics.
Key facts
Founded: 2016 · Headquarters: Mumbai, India